Engineering Next-Generation In Vivo “Off-the-Shelf” CAR-T Therapies to Overcome Barriers in Solid Tumors
- Designing multi-armored T cell therapies to overcome tumor resistance mechanisms
- Engineering armored CAR and TCR constructs specifically optimized for in vivo cell therapies
- Advancing first- and best-in-class multi-armored in vivo cell therapies for solid tumors